P&G Builds Heartburn Market Lead, Continues Focus On Whitening Products
This article was originally published in The Tan Sheet
Executive Summary
Prilosec OTC's sustained momentum helped produce a 17% gain in unit volume for Procter & Gamble's health care segment in the second quarter (ended Dec. 31). Sales for the unit rose 22% to $1.91 bil. and earnings advanced 32% to $333 mil